Related references
Note: Only part of the references are listed.SGLT2 inhibitors improve plasma atherogenic biomarkers in patients with type 2 diabetes: a real-world retrospective observational study
Eren Imre et al.
MINERVA ENDOCRINOLOGY (2023)
Glucose biosensors in clinical practice: principles, limits and perspectives of currently used devices
Salvatore Andrea Pullano et al.
THERANOSTICS (2022)
Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia
Tim Cundy et al.
DIABETES CARE (2021)
Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
Maria Mirabelli et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences
Gianfranco di Giuseppe et al.
MINERVA ENDOCRINOLOGY (2021)
Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation
Lucrezia Ferrario et al.
CLINICOECONOMICS AND OUTCOMES RESEARCH (2021)
Diabetes Technology: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes
Maria Mirabelli et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Potential Benefits and Harms of Novel Antidiabetic Drugs during COVID-19 Crisis
Maria Mirabelli et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
Yun Kyung Cho et al.
PLOS ONE (2019)
Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus
Maria Mirabelli et al.
JOURNAL OF DIABETES RESEARCH (2019)
Glycemic Targets: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study
Jared P. Reis et al.
DIABETES CARE (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Glycated albumin: a potential biomarker in diabetes
Priscila Aparecida Correa Freitas et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2017)
Multicenter evaluation of an enzymatic method for glycated albumin
Renata Paleari et al.
CLINICA CHIMICA ACTA (2017)
Glycated albumin: correlation to HbA1c and preliminary reference interval evaluation
Roberto Testa et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Qualitative assessment of user experiences of a novel smart phone application designed to support flexible intensive insulin therapy in type 1 diabetes
Brigid A. Knight et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2016)
Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
Julio Rosenstock et al.
DIABETES CARE (2014)
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia
J. Rosenstock et al.
DIABETES OBESITY & METABOLISM (2013)
Apolymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
Eusebio Chiefari et al.
SCIENTIFIC REPORTS (2013)
A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
Jan Basile
POSTGRADUATE MEDICINE (2011)
Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes
Yoshifumi Saisho et al.
DIABETOLOGY INTERNATIONAL (2011)
The Co-Occurrence of Chronic Diseases and Geriatric Syndromes: The Health and Retirement Study
Pearl G. Lee et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes
Kazutomi Yoshiuchi et al.
ENDOCRINE JOURNAL (2008)
Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma
Rita Paroni et al.
CLINICAL BIOCHEMISTRY (2007)
Glycated albumin is low in obese, non-diabetic children
R Nishimura et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2006)
An enzymatic method for the measurement of glycated albumin in biological samples
T Kouzuma et al.
CLINICA CHIMICA ACTA (2002)
Share Paper
